Effect of Sequential vs. Simultaneous Dual Growth Factor Release from Structured Heparin-Poly-Electrolyte Multilayer Coatings on Peri-Implant Bone Formation and Angiogenesis in Pig Mandibles

Effect of Sequential vs. Simultaneous Dual Growth Factor Release from Structured Heparin-Poly-Electrolyte Multilayer Coatings on Peri-Implant Bone Formation and Angiogenesis in Pig Mandibles

The aim of the present study was to test the sequential and simultaneous release of rhBMP2 and rhVEGF165 from poly-<span style="font-variant: small-caps;">l</span>-lysine-heparin (PLL-Hep) poly-electrolyte multilayer (PEM) coating on titanium surfaces for their ability to enhan...

Bibliografske podrobnosti
Main Authors:	Philipp Kauffmann, Susanne Wolfer, Christina Behrens, Pauline Schlosser, Christian Dullin, Uwe Schirmer, Klaus Liefeith, Henning Schliephake
Format:	Article
Jezik:	English
Izdano:	MDPI AG 2025-02-01
Serija:	Journal of Functional Biomaterials
Teme:	heparin poly-electrolyte multilayer bone morphogenic proteins vascular endothelial growth factor controlled release biofunctionalization
Online dostop:	https://www.mdpi.com/2079-4983/16/2/67

Podobne knjige/članki

The Auxiliary Role of Heparin in Bone Regeneration and its Application in Bone Substitute Materials
od: Jing Wang, et al.
Izdano: (2022-05-01)

Tailored Polyelectrolyte Multilayer Systems by Variation of Polyelectrolyte Composition and EDC/NHS Cross-Linking: Physicochemical Characterization and In Vitro Evaluation
od: Uwe Schirmer, et al.
Izdano: (2022-06-01)

Repair of Rat Calvarial Critical-Sized Defects Using Heparin-Conjugated Fibrin Hydrogel Containing BMP-2 and Adipose-Derived Pericytes
od: Gulshakhar Kudaibergen, et al.
Izdano: (2024-04-01)

Heparinization of the bovine pericardial scaffold by layer-by-layer (LBL) assembly technique
od: My Thi Ngoc Nguyen, et al.
Izdano: (2022-06-01)

The use of heparin and heparin-like molecules in cancer treatment: a review
od: Johnny Atallah, et al.
Izdano: (2020-01-01)

Recombinant perlecan domain V covalently immobilized on silk biomaterials via plasma immersion ion implantation supports the formation of functional endothelium
od: Lau, Kieran, et al.
Izdano: (2024)

Not Just Anticoagulation—New and Old Applications of Heparin
od: Lixuan Zang, et al.
Izdano: (2022-10-01)

IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?
od: Fahad Al-Eidan
Izdano: (2015-04-01)

Blood-Vessel Mimicking Structures by Stereolithographic Fabrication of Small Porous Tubes Using Cytocompatible Polyacrylate Elastomers, Biofunctionalization and Endothelialization
od: Birgit Huber, et al.
Izdano: (2016-04-01)

Biofunctionalization of Endolysins with Oligosacharides: Formulation of Therapeutic Agents to Combat Multi-Resistant Bacteria and Potential Strategies for Their Application
od: Carlos E. Camacho-González, et al.
Izdano: (2022-03-01)

The effect of heparins on plasma concentration of heparin-binding protein: a pilot study
od: Halla Halldorsdottir, et al.
Izdano: (2024-03-01)

Heparin-induced thrombocytopenia
od: Shaikh Nissar
Izdano: (2011-01-01)

Biofunctionalized composite scaffold to potentiate osteoconduction, angiogenesis, and favorable metabolic microenvironment for osteonecrosis therapy
od: Tongtong Zhu, et al.
Izdano: (2022-03-01)

Incidence of anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia in medical patients
od: Mahmut Yüksel, et al.
Izdano: (2009-12-01)

Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use
od: Paola Chiodelli, et al.
Izdano: (2015-04-01)

Heparin-induced thrombocytopenia: an update
od: Franchini Massimo
Izdano: (2005-10-01)

Heparin-Independent and Heparin-Dependent Anti-CXCL4 Antibodies Have a Reciprocal Expression in a Systemic Sclerosis Patients’ Cohort
od: Raffaella Palazzo, et al.
Izdano: (2022-12-01)

Expanding the Applicability of Electroactive Polymers for Tissue Engineering Through Surface Biofunctionalization
od: Beatriz Leiva, et al.
Izdano: (2025-02-01)

Impact of nanotechnology at heterogeneous interphases @ Sustainability
od: Pankaj Tomar
Izdano: (2024-03-01)

Optimization of Glutathione Adhesion Process to Modified Graphene Surfaces
od: Witold Jakubowski, et al.
Izdano: (2021-03-01)

Do we need retarded delivery of bone growth factors in facial bone repair? An experimental study in rats
od: N Moser, et al.
Izdano: (2018-05-01)

The evaluations of frequency distribution heparin resistance during coronary artery bypass graft
od: Kaivan Bagheri, et al.
Izdano: (2014-01-01)

Inactivation of Heparin by Cationically Modified Chitosan
od: Barbara Lorkowska-Zawicka, et al.
Izdano: (2014-06-01)

Heparin Mimetics: Their Therapeutic Potential
od: Shifaza Mohamed, et al.
Izdano: (2017-10-01)

Evaluation of molecular mechanisms of heparin-induced angiogenesis, in human umbilical vein endothelial cells
od: Sadia Fazil, et al.
Izdano: (2021-09-01)

Evaluation of the use of a heparin dose‐response test in dogs to determine the optimal heparin dose during intravascular procedures and assessment of the in vitro heparin response in healthy dogs
od: A. Hellemans, et al.
Izdano: (2024-05-01)

Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications
od: Niranjan Koirala, et al.
Izdano: (2025-02-01)

Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
od: Jonathan S. Williams, et al.
Izdano: (2018-01-01)

Jak-Stat pathway induces Drosophila follicle elongation by a gradient of apical contractility
od: Hervé Alégot, et al.
Izdano: (2018-02-01)

Dpp controls growth and patterning in Drosophila wing precursors through distinct modes of action
od: Pablo Sanchez Bosch, et al.
Izdano: (2017-07-01)

Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin
od: OLIVERA M. BOSNIĆ, et al.
Izdano: (2009-04-01)

Heparin, Heparan Sulphate and Sepsis: Potential New Options for Treatment
od: John Hogwood, et al.
Izdano: (2023-02-01)

Binding of hepatic lipase to heparin: identification of specific heparin-binding residues in two distinct positive charge clusters
od: Rebecca A. Sendak, et al.
Izdano: (2000-02-01)

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era
od: Kayla Torppey, et al.
Izdano: (2023-10-01)

Comparison of Pregnancy Outcomes of Low Molecular Weight Heparin with Unfractionated Heparin in the Treatment of Recurrent Abortion Secondary to Antiphospholipid Syndrome
od: M Janghorbani, et al.
Izdano: (2013-09-01)

Heparin: Past, Present, and Future
od: Eziafa I. Oduah, et al.
Izdano: (2016-07-01)

Does ‘heparin-induced thrombocytopenia’ hit our minds?
od: Arun R. Thangavel, et al.
Izdano: (2016-08-01)

Use of heparin in neurointervention
od: M. Zenteno, et al.
Izdano: (2013-12-01)

Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
od: Harry Menon, et al.
Izdano: (2018-10-01)

An Ovarian Cancer Patient Presenting Heparin - Induced Thrombocytopenia after use of Low - Molecular - Weight Heparin: A Case Report of Rare Condition
od: Yasin Durmuş, et al.
Izdano: (2019-12-01)